NCT06598904

Brief Summary

First dental visit experience is strongly correlated with dental anxiety, the aim of this protocol is to explore the efficacy of olfactory aromatherapy for the reduce of dental anxiety and pain in first-visit patient.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
120

participants targeted

Target at P50-P75 for not_applicable

Timeline
5mo left

Started Sep 2024

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress82%
Sep 2024Sep 2026

First Submitted

Initial submission to the registry

September 12, 2024

Completed
7 days until next milestone

First Posted

Study publicly available on registry

September 19, 2024

Completed
1 day until next milestone

Study Start

First participant enrolled

September 20, 2024

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 31, 2025

Completed
1.5 years until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2026

Expected
Last Updated

September 19, 2024

Status Verified

September 1, 2024

Enrollment Period

6 months

First QC Date

September 12, 2024

Last Update Submit

September 12, 2024

Conditions

Keywords

dental anxietyaromatherapyfirst dental visit

Outcome Measures

Primary Outcomes (2)

  • Anxiety scale 1 - Modified Dental Anxiety Scale (MDAS)

    The Modified Dental Anxiety Scale (MDAS) consists of 4 questions each with a 5 category rating scale, ranging from 'not anxious' to 'extremely anxious', hence, the total score varies from 4 to 20, with higher obtained scores describing more elevated levels of dental anxiety. MDAS is recorded before, during and after operation.

    5 minutes before operation/during operation (immediately after the most painful procedure)/immediately after operation.

  • Pain scale - Visual Analog Scale (VAS)

    The visual analog scale (VAS) is a validated, subjective measure for acute and chronic pain. Scores are recorded by making a handwritten mark on a 10-cm line that represents a continuum between "no pain" and "worst pain." VAS is recorded before, during and after operation.

    5 minutes before operation/during operation (immediately after the most painful procedure)/immediately after operation.

Secondary Outcomes (5)

  • Anxiety scale 2 - State-Trait Anxiety Inventory for State Anxiety (STAI-S)

    5 minutes before operation/ immediately after operation.

  • Vital sign 1 - systolic blood pressure (SBP)

    5 minutes before operation/during operation (immediately after the most painful procedure, and every 10min after)/immediately after operation.

  • Vital sign 2 - diastolic blood pressure (DBP)

    5 minutes before operation/during operation (immediately after the most painful procedure, and every 10min after)/immediately after operation.

  • Vital sign 3 - heart rate (HR)

    5 minutes before operation/during operation (immediately after the most painful procedure, and every 10min after)/immediately after operation.

  • Vital sign 4 - oxygen saturation (SpO2)

    5 minutes before operation/during operation (immediately after the most painful procedure, and every 10min after)/immediately after operation.

Study Arms (3)

Group 1: single-note lavender essential oil

EXPERIMENTAL

Aroma diffuser with single-note lavender essential oil.

Other: Aroma diffuser with single-note lavender essential oil

Group 2: single-note orange essential oil

EXPERIMENTAL

Aroma diffuser with single-note orange essential oil

Other: Aroma diffuser with single-note orange essential oil

Group 3: deionized water

PLACEBO COMPARATOR

Aroma diffuser with deionized water.

Other: Aroma diffuser with deionized water

Interventions

In a space of 3\*4\*2.6 cubic meters, positioned 10 cm away from the patient, add 4-6 drops (each drop being 0.05 ml) of 100% concentration single-note lavender essential oil into the aroma diffuser reservoir containing 120 ml of water.

Group 1: single-note lavender essential oil

In a space of 3\*4\*2.6 cubic meters, positioned 10 cm away from the patient, add 4-6 drops (each drop being 0.05 ml) of 100% concentration single-note orange essential oil into the aroma diffuser reservoir containing 120 ml of water.

Group 2: single-note orange essential oil

In a space of 3\*4\*2.6 cubic meters, positioned 10 cm away from the patient, add 4-6 drops (each drop being 0.05 ml) of water into the aroma diffuser reservoir containing 120 ml of deionized water.

Group 3: deionized water

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Patients who never visited dental clinics before;
  • Patients who need dental treatment, such as resin filling, root canal treatment, periodontal initial treatment, tooth extraction, etc;
  • Patients and their guardians who are able to understand the purpose of the study and volunteer to take part in the study;
  • Patients who are intellectually sufficient to complete the anxiety scale;
  • Be able to complete all assessments and follow-up during the study.

You may not qualify if:

  • Patients who are allergic to the ingredients of the essential oils used in the experiment or to the materials used in the dental treatment;
  • Patients who underwent only an oral examination;
  • Patients with severe heart disease, hypertension, respiratory disease, or other systemic conditions that were not eligible for trial participation;
  • Pregnant or lactating women;
  • People with depressive symptoms, anxiety disorders or other mental illnesses that affect their mood state;
  • People who are using sedative or analgesic drugs;
  • Recent or current users of essential oils;
  • Any circumstances considered by the investigator to be inappropriate for participation in this study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

West China Hospital of Stomatology SIchuan University

Chengdu, Sichuan, 610041, China

Location

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Post Doctor

Study Record Dates

First Submitted

September 12, 2024

First Posted

September 19, 2024

Study Start

September 20, 2024

Primary Completion

March 31, 2025

Study Completion (Estimated)

September 30, 2026

Last Updated

September 19, 2024

Record last verified: 2024-09

Locations